Author: Hayley

Exclusive Partnership with BIOKÉ to Advance 3D Cell Culture in Benelux

March 1, 2025 – Gelomics is pleased to announce a new strategic partnership with BIOKÉ, a business unit within Cell Signaling Technology Europe B.V. since 2009, a leading provider of innovative life science solutions. Under this agreement, BIOKÉ will serve as Gelomics’ exclusive distributor in the Benelux region, including Belgium, the Netherlands, and Luxembourg. This […]

Gelomics Expands Global Presence with New Distribution Partner, Voden Medical In Italy

Gelomics proudly announces a strategic partnership with Voden Medical. Voden Medical is a renowned provider of advanced diagnostic and life science solutions in Italy. Under this agreement, Voden Medical will serve as Gelomics’ exclusive distributor in the Italian market. This partnership, effective January 2025, marks a significant step forward in Gelomics’ mission to bring our […]

Conference | Join Gelomics at AACR 2025 in Chicago

We’re excited to showcase our latest innovations in 3D cell culture at AACR this April. If you’re attending, let’s connect! Schedule a meeting with our team to explore how our technology can accelerate your cancer research. 📅 April 25-30, 2025 📍 Booth #444, McCormick Place Convention Center Chicago, Illinois 🔗 Schedule a meeting today: info@gelomics.com View other events […]

On-demand Seminar | LunaGel™ Transforming 3D Cell Culture for Biomedical Breakthroughs

Discover the future of biomedical research with LunaGel™, an innovative 3D cell culture platform by Gelomics. Join Dr. Christoph Meinert, CEO of Gelomics, for an exclusive seminar exploring how LunaGel™ is revolutionizing the creation of realistic human tissue models—bridging the gap between traditional cell culture systems and cutting-edge research. Learn how LunaGel™ empowers researchers with: Dr. Meinert […]

Gelomics partners with Bucher Biotec AG for Product Distribution in Switzerland

Gelomics is pleased to announce a new strategic partnership with Bucher Biotec AG, a leading provider of advanced life science solutions in Switzerland & Lichtenstein. Under this agreement, Bucher Biotec will serve as Gelomics’ exclusive distributor across the Swiss market. This partnership marks an important milestone for Gelomics as we expand our presence in Europe. […]